Pacritinib and Mitotane: Interaction Details
- Mitotane
- Lysodren
- Pacritinib
- Vonjo
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Pacritinib and Mitotane interaction:
What Happens When You Take Pacritinib With Mitotane
What can happen when they are taken together (rated Contraindicated)
Reduced pacritinib exposure and reduced of pacritinib
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Using pacritinib together with a strong is , since the inducer may lower pacritinib exposure and could also diminish its efficacy. In a study where rifAMPin, a strong CYP3A4 inducer, was given at 600 mg once daily for 10 days and a single 400 mg dose of pacritinib was then added, pacritinib fell by 0.13-fold and fell by 0.49-fold.1
The Pacritinib and Mitotane Interaction, Explained
Mitotane can make pacritinib work less well. Mitotane speeds up an enzyme in your liver () that breaks down pacritinib. With that enzyme working faster, your body clears pacritinib quicker, so less of it stays in your blood. That could mean it doesn't control your myelofibrosis symptoms or spleen size as well as it should.
This combination is on the list, which means it is normally avoided. Please don't stop or change either medicine on your own. Talk with your pharmacist or doctor, who can review your options and decide on the safest plan for you.
Mechanism: Mitotane is a strong . Pacritinib is cleared mainly via CYP3A4, so increases and lowers exposure, with a risk of reduced .
- Magnitude: Rifampin 600 mg daily for 10 days reduced pacritinib (0.13-fold) and (0.49-fold) after a single 400 mg dose. Mitotane-specific data are not cited.
- Onset: Unspecified. Mitotane has a long , so induction may persist after discontinuation.
- Evidence: Probable (PK data with a surrogate strong inducer).
- Management: with strong CYP3A4 is . Consider alternative therapy and review the regimen with the prescriber.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Pacritinib and Mitotane Interact
The likely mechanism
of -mediated of pacritinib
How to Manage the Pacritinib and Mitotane Interaction
The documented advice is that pacritinib should not be used together with strong like mitotane, because pacritinib levels may drop and it may work less well.
- Your care team will typically review whether both medicines are truly needed and consider an alternative approach.
- Do not stop or change either medicine on your own.
- Tell your pharmacist and prescriber about every medicine and supplement you take, and raise this combination with them if it applies to you.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Pacritinib or Mitotane need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: VONJO oral capsules, pacritinib oral capsules
In a study, when a single 400 mg dose of pacritinib was given together with rifAMPin (a strong ) at 600 mg once daily for 10 days, pacritinib fell by 0.13-fold and fell by 0.49-fold.1
Pacritinib and Mitotane: Common Questions
How serious is the Pacritinib and Mitotane interaction?
It is rated . These should generally not be used together.
How is the Pacritinib and Mitotane interaction managed?
The documented advice is that pacritinib should not be used together with strong like mitotane, because pacritinib levels may drop and it may work less well. Your care team will typically review whether both medicines are truly needed and consider an alternative approach. Do not stop or change either medicine on your own. Tell your pharmacist and prescriber about every medicine and… Management is individual — always follow your own care team's guidance.
Does taking Pacritinib and Mitotane at different times of day help?
No. Taking them at different times of day does not prevent this one. Mitotane speeds up , an enzyme that breaks down pacritinib, so pacritinib can be cleared faster. That change lasts while mitotane is being taken and can continue for a while after the last dose.
Your pharmacist or prescriber can tell you how they will manage it.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Pacritinib and Mitotane Interaction
Ask in your own words about taking Pacritinib and Mitotane together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: VONJO(R) oral capsules, pacritinib oral capsules. CTI BioPharma Corp (per FDA), Seattle, WA, 2024. DailyMed
Other Serious Interactions of Pacritinib and Mitotane
Also serious with Mitotane
- DoravirineContraindicated
- FostemsavirContraindicated
- Lenacapavir OralContraindicated
- LurasidoneContraindicated
Also serious with Pacritinib
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Mitotane
- Activated CharcoalMajor
- Slippery ElmModerate
- GlucomannanModerate
- TragacanthModerate
- Coffee CharcoalModerate
- European MandrakeModerate
- Guar GumModerate
- Gum ArabicModerate
- + 9 more
With Pacritinib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- Sida CordifoliaMajor
- + 155 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together. This interaction.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.